October 5, 2017
#CIMCon17: learn from experts moving genomic discoveries into patient care
By Sharon Rosen
Mayo Clinic is a leader in moving important advancements in precision medicine from the laboratory into patient care, offering hope and healing. The Individualizing Medicine Conference: Advancing Care Through Genomics gives medical providers and scientists the opportunity to learn firsthand the newest ways genomic medicine is improving care for patients. The Mayo Clinic Center for […]
Tags: #CIMCon17, #Consumer genomics, #Dr. David Ledbetter, #Dr. David Relman, #Dr. Judy Cho, #Dr. Rachel Tyndale, #Dr. Rob Knight, #Dr. Robert Green, #Dr. Stephanie Devaney, #Dr. William Gahl, #genomic testing, #Home DNA tests
October 3, 2017
Liquid biopsies: detecting and treating cancer sooner
By Sharon Rosen
What if a blood test could discover cancer before a tumor first appears or before the first signs of cancer recurrence are seen by a radiology study? In fact, these types of blood tests, often called liquid biopsies, are already changing clinical care for patients with cancer. Researchers and physicians in Mayo Clinic Center for […]
Tags: #blood tests, #cancer treatment, #cell-free DNA testing, #CIMCon17, #circulating tumor cells, #Dr. Minetta Liu, #Individualizing Medicine 2017, #liquid biopsies, Advanced Cancer, breast cancer, cancer, cancer screening
September 27, 2017
A genetic approach to cancer treatment
By Sharon Rosen
Article by Kristin Clift The medical community has historically defined and treated cancer based on where it is found in the body, such as the breast, lung or colon. So what has changed? The FDA has recently started to approve treatments based on the genetic makeup of cancer rather than where the cancer is located. […]
Tags: #cancer treatment, #CIMCon17, #DNA analysis, #Genetic Epidemiology and Risk Assessment Program, #Individualizing Medicine 2017, #targeted therapies, Advanced Cancer, cancer, center for individualized medicine, DNA Sequencing, Dr. Alexander Parker, Genetic Testing
September 25, 2017
Study evaluates effectiveness of deep genomic profiling in clinical setting
Genomic profiling is used today for patients with advanced cancers to help develop new ways to diagnose and treat their disease and offer an individualized treatment plan. While gene panel testing is relatively commonplace, there are many barriers to using new and more sophisticated DNA technologies. According to Mitesh Borad, M.D., an oncologist at the […]
Tags: #cancer treatment, #CIMCon17, #Dr. Mitesh Borad, #genetic profiling, #Individualizing Medicine 2017, #long-insert whole genome, #Nature scientific Reports, #targeted therapies, #whole transcriptome sequencing, Advanced Cancer, center for individualized medicine, mayo clinic
September 19, 2017
How does a genomic tumor board impact patient care?
The outcomes from a Mayo Clinic study published in Oncotarget found value in having an established genomic tumor board, and using genomics for certain patients. The experience of the Genomic Tumor Board has promoted an evolution in the practice according to Alan Bryce, M.D., a Mayo Clinic oncologist, and co-first author on the study. “There […]
Tags: #cancer treatment, #CIMCon17, #Dr. Jan Egan, #genetic testing fees, #Genomic analysis, #Genomic Tumor Board, #Individualizing Medicine 2017, #targeted therapies, Advanced Cancer, cancer, center for individualized medicine, Dr. Alan Bryce
September 30, 2013
Individualized Medicine Clinic Celebrates One Year Anniversary
By AJ Montpetit
Today marks the 1 year anniversary of the Mayo Clinic Center for Individualized Medicine opening the proverbial doors to begin seeing patients in the Individualized Medicine Clinic (IM Clinic). The opening of the IM Clinic was a collaborative effort across multiple departments across the three campuses of Mayo Clinic. The two Service Lines, Advanced Cancer Patients […]
Tags: Advanced Cancer, cancer, center for individualized medicine, DNA, exome, genome, genomics, IM Clinic, individualized medicine, Individualized Medicine Clinic, rare disease, undiagnosed disease